Pretty amazing experience at #TCT2023 "Featured Technological Trends: AI in MedTech Innovation" presenting an interim report from @GPx_Boston 250-patient TRIBE-HF 2 study featuring algo performance of 93% sensitivity/99.5% specificity to non-invasively predict NT-proBNP spikes.

During @sxsw, a pitch competition showcases startups’ innovative technology. Check out our picks for some of the most innovative startups showcased at SXSW Pitch 2023. @carbon_reform @GPx_Boston @DetectDeepfakes @imvizar @pentopx https://t.co/RPRi6aGJ6v

Congrats to all the #SXSWPitch ‘23 category winners!!! @deepfake_detect @ClimatiqHQ @PentoPix @GPx_Boston @ChicagoSchools SXD AI @NumbersProtocol @UrbanMachine1

Great job Javi for pitching @GPx_Boston and our #blooslessbloostests at the @sxsw Pitch Competition Final! #SXSW2023 #sxswpitch

At #acc23 with my co-founder Javier Echenique! Caffeinated and ready to learn/meet everyone! Come join us at Future Hub Booth 18! @GPx_Boston #Bloodlessbloodtests, #heartfailure, #nola

2023 SXSW Pitch Finalist General Prognostics (GPx) Proud of the #tribe at @GPx_Boston for being recognized and selected as one of the five @sxsw Pitch Finalists among a group of #startups from across the world! SXSW Pitch is the marquee event of #SXSW Conference & Festivals

#STRONGHF results from high-intensity #heartfailure therapies + #NTproBNP monitoring were so positive that the study was ended early as it would be unethical to continue with standard care. #bloodlessbloodtests are the future https://t.co/qgCMcMZlWU #cardiotwitter @Roche

We received hundreds of applications, full of inspiring tech innovations, from over 40 countries for the XTC Startup Competitions @ CES 2023! 🤯 Click here to find out who our finalists are! 👉 https://t.co/FwszZmSr67 @CES

We're very lucky to have had @radcliffeCARDIO meet with us to discuss the potential of #bloodlessbloodtests and #CardioID. Thank you for the opportunity! https://t.co/cIH7NzIQBc

Check out this video and learn what motivates each and every one of us at General Prognostics (GPx) and how we see the future direction of #CardioID and #Bloodlessbloodtests. #healthequity, #heartfailure, #cardiotwitter

"We are creating a product that can be implemented at scale in more developing economies where people don't have the money to have advanced monitoring. We aim to have a solution for all the world to use."

Today begins Global #HealthEquity Week (October 24-28 - https://t.co/OaXojAJIr5) and I thought to share this quote from our very own Javier Echenique in an interview by @radcliffeCARDIO. https://t.co/0ZONZJFiOK

Each year, the @ucsfhealthaward recognizes innovative technologies in #digitalhealth. We're thrilled to announce our nomination to the Rising Star track! Winners announced at HLTH Conference in Las Vegas, November 14. Info to support the Awards: https://t.co/1oWr7AMwv2. #DHA2022

https://t.co/LHCIg1yKUH #bloodlessbloodtest #cardiotwitter #heartfailure

#startup #funding #news ~@vincere_health raises customer-led #strategic #funding round of $1.75M ~Digital #blood #biomarkers firm @GPx_Boston raises $3.25M ~@BlueZoneToronto secures $8M of institutional #financing

We are grateful for your continued support in the development of #Bloodlessbloodtests! #digitalhealth #remotepatientmonitoring #heartfailure #cardiotwitter

Congratulations to Dr. Shah, Eva Adams, Kartik Munshi, and the team at @KUMedCenter for the continued success on enrolling their CardioID patients into #TRIBEHF2 #ClinicalTrial.

Several startups are diving into remote patient monitoring, a fast-growing industry that saw an increase in funding post-pandemic. We take a look at the industry and implications for the sector going forward. https://t.co/jOPLksJmBl

#cardiotwitter #bloodlessbloodtest #HeartFailure https://t.co/vxqr2MBnp4

Very pleased to get top-tier coverage for GPx's news with Crunchbase News and additionally by StrictlyVC. Thank you @StrictlyVC and @Cookie! @GPx_Boston #API4Blood